Currently much of academic and translational validation is done through output measurement. We are all familiar with rankings, impact factors and the like. For research institutes affliated with university hospitals the translation to, and impact on clinical practice is of great importance as well.
In this session we will be discussing a new model – value-based indicators, where research is being evaluated based on the value it adds to clinical practice. This builds on the Responsible Research and Innovation (RRI) initiative as well as the value & outcomes based healthcare movement. RRI implies that societal actors work together during the whole research and innovation process in order to better align both the process and its outcomes with the values, needs and expectations of society. Under value-based care, providers are geared towards and rewarded for helping patients improve their health, reduce the effects and incidence of chronic disease, and live healthier lives in an evidence-based way
- Responsible Research Innovation (RRI): What does it mean for patients?
- Impact of research in a clinical setting
- Lessons learned from the implementation of patient pathways